Claritev Corporation
Health
Performance
8.8
Risk
Sell
Buy
Curious about the Scores? Learn more.

Claritev Corporation stock rating and score history

All changes in ratings, performance and outlook tracked over time.

11.07.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
11.07.2026
Momentum tanked. Clearly underperforming.
15.11.2025
Red alert. Risk levels out of control.
CTEV
Claritev Corporation
26.84
+2.72%
8.8
Sell
Buy
Claritev Corporation

Claritev Corporation stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Claritev Corporation do? Business model and key facts

Get the full picture of Claritev Corporation: what it builds, where it operates, and how it makes money.

Claritev Corporation Profile

Sector: Healthcare

Industry: Medical - Healthcare Information Services

Employees (FY): 3000

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

shop
Company facts
Travis S. Dalton
CEO
3000
Employees worldwide
shop
Performance
-47.52%
Last 12 months
shop
Growth
$965.41M
Revenue year
$-284,282,000
Net income
shop
Valuation
$387.16M
Market Cap
-2.47
Price/Earnings Ratio

Stocks related to Claritev Corporation

Selected based on industry alignment and relative market positioning.

TBRG
TruBridge, Inc.
26.24
+0.00%
5.8
Sell
Buy
TruBridge, Inc.
NRC
NRC Health
19.47
-0.36%
6.4
Sell
Buy
NRC Health
PHR
Phreesia, Inc.
11.42
-0.61%
7.4
Sell
Buy
Phreesia, Inc.
EVH
Evolent Health, Inc.
3.59
+16.56%
8.8
Sell
Buy
Evolent Health, Inc.
SY
So-Young International Inc.
2.11
+0.96%
10.0
Sell
Buy
So-Young International Inc.

Events and news impacting Claritev Corporation stock

Earnings, coporate decisions and industry developments that can affect the share price.

Claritev Corporation fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.